← Leaderboards
Ruth Dubin
University Of California, San Francisco
$4,143,897
Attributed
$8,694,282
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2012–24$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,694,282 · 5
By mechanism
R01$5,815,278 · 2
U01$1,859,218 · 1
K23$878,211 · 1
R03$141,575 · 1
Top collaborators
- Peter Ganz13 shared
- Rajat Deo9 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Priscilla Y. Hsue$28,957,856
- Allison R Webel$6,329,040
- Nisha Bansal$11,641,413
- Catherine Elizabeth Oldenburg$6,320,431
- Kirsten Bibbins-Domingo$41,983,852
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantCardiovascular SystemCohortCardiovascular DiseasesCardiovascular Risk FactorBiologicalPathway InteractionsNovel TherapeuticsBiological MarkersHeart FailureDesignMortalityCardiacRisk FactorsEventPathway AnalysisProtein BiomarkersProteinsProteomicsInvestigationAptamerLeadRaceRenal Function
Grant awards (20)
Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics$732,468
R01 · FY2024 · HL · contact PI
Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis$569,975
R01 · FY2024 · HL
Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics$721,496
R01 · FY2023 · HL · contact PI
Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis$562,664
R01 · FY2023 · HL
Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics$801,559
R01 · FY2022 · HL · contact PI
Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis$569,270
R01 · FY2022 · HL
Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics$1,140,149
R01 · FY2021 · HL · contact PI
Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis$717,697
R01 · FY2021 · HL
Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease$320,000
U01 · FY2020 · DK
Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease$146,168
U01 · FY2019 · DK
Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease$349,999
U01 · FY2018 · DK
Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease$692,874
U01 · FY2017 · DK
Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease$350,177
U01 · FY2016 · DK
Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD$172,217
K23 · FY2016 · DK · contact PI
Novel Echocardiographic Methods to Characterize Heart Failure in ESRD$67,732
R03 · FY2016 · DK · contact PI
Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD$174,111
K23 · FY2015 · DK · contact PI
Novel Echocardiographic Methods to Characterize Heart Failure in ESRD$73,843
R03 · FY2015 · DK · contact PI
Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD$175,910
K23 · FY2014 · DK · contact PI
Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD$177,436
K23 · FY2013 · DK · contact PI
Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD$178,537
K23 · FY2012 · DK · contact PI